APPLICATION
ANDA210546
TYPE
ANDA
ORIGINAL APPROVAL
2018-12-28
LATEST ACTION
2024-07-15
ROUTE
ORAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Discontinued
Products
CLOBAZAMDiscontinued
CLOBAZAM 2.5MG/ML · SUSPENSION · ORAL
Approval history
2024-07-15Labeling · Supplement 5 · standardAP
2023-05-01Labeling · Supplement 4 · standardAP
2021-12-03Labeling · Supplement 2 · standardAP
2018-12-28UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.